We are live on ! Find out more
FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

32 hedge funds and large institutions have $116M invested in Fusion Pharmaceuticals Inc. Common Shares in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

20% less funds holding

Funds holding: 40 → 32 (-8)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

47% less capital invested

Capital invested by funds: $221M → $116M (-$105M)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
32
Holders Change
-8
Holders Change %
-20%
% of All Funds
0.49%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
3
Increased
6
Reduced
8
Closed
10
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.19M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$749K
3
WP
Woodline Partners
California
+$554K
4
AA
AlphaCentric Advisors
Puerto Rico
+$178K
5
E
Ergoteles
New York
+$68.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.52M
2
Millennium Management
Millennium Management
New York
-$213K
3
PA
Perceptive Advisors
New York
-$172K
4
Goldman Sachs
Goldman Sachs
New York
-$160K
5
Victory Capital Management
Victory Capital Management
Texas
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank Julius Baer & Co
26
Bank Julius Baer & Co
Switzerland
$8K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$5K -$9.32K -1,494 -56%
TWC
28
TD Waterhouse Canada
Ontario, Canada
$4.52K +$5.46K +875 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$4K -$9.36K -1,500 -64%
S
30
SignatureFD
Georgia
$1K – – –
APA
31
American Portfolios Advisors
New York
$125 – – –
Millennium Management
32
Millennium Management
New York
– -$213K -26,925 Closed
Goldman Sachs
33
Goldman Sachs
New York
– -$160K -20,149 Closed
DekaBank Deutsche Girozentrale
34
DekaBank Deutsche Girozentrale
Germany
– -$105K -13,000 Closed
UBS Group
35
UBS Group
Switzerland
– -$26.5K -4,251 -99%
Citigroup
36
Citigroup
New York
– -$19K -2,414 Closed
Simplex Trading
37
Simplex Trading
Illinois
– -$9.11K -1,460 Closed
Bank of America
38
Bank of America
North Carolina
– -$11K -1,401 Closed
PCM
39
Penserra Capital Management
California
– -$7K -980 Closed
PHK
40
Point72 Hong Kong
Hong Kong
– -$2K -240 Closed
Daiwa Securities Group
41
Daiwa Securities Group
Japan
– -$1K -78 Closed
1
2

FUSN Hedge Fund Activity: Q4 2021 in Review

32 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q4 2021, worth a combined $116M — down 47% from $221M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FUSN and 3 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 6 added.

The largest buyer was Point72 Asset Management, adding an estimated $1.19M. The largest seller was BlackRock, cutting an estimated $2.52M.

  • 32 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q4 2021, down from 40 in Q3 2021.
  • Funds reported $116M of Fusion Pharmaceuticals Inc. Common Shares stock for Q4 2021, down 47% quarter-over-quarter.
  • 3 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q4 2021 and 10 closed out, a net change of -7 holders.
  • The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q4 2021 was Point72 Asset Management, an estimated $1.19M added.
  • The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q4 2021 was BlackRock, an estimated $2.52M sold.

Based on aggregated 13F filings for Q4 2021.